Clinical Data News
Most Popular Clinical Data Story
Merck KGaA pulls ahead in hot oral MS drug race
Researchers for Merck KGaA say that new analysis of the late-stage data for their oral drug cladribine highlight the drug's potential as a new therapy for multiple sclerosis. Patients taking a short Read more...
Latest Headlines
- August 30, 2011
- February 23, 2011
- February 22, 2011
- January 24, 2011
- February 9, 2010
- September 11, 2009
- August 14, 2009
- August 11, 2009
- April 3, 2009
- November 20, 2008
- November 3, 2008
- October 28, 2008
- October 13, 2008
- October 8, 2008
- August 5, 2008
- September 6, 2007
- June 14, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
